UNSPSC 51162042: Beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide

Beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide is an inhalable fixed-dose combination drug used to treat chronic obstructive pulmonary disease

UNSPSC 51162042 Beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide is a Commodity code that nominally describes a specific pharmaceutical combination product, but the recent state and local opportunities tagged under this code show no relevant activity; the source contains one administrative notice from Williamson County, Texas about a purchasing department relocation and one opportunity from Seminole County, Florida for naloxone and drug deactivation systems that are unrelated to the named pharmaceutical formulation. The remaining opportunities in the source span pharmaceutical procurement, medical device supply, healthcare services contracting, vendor networking events, and cooperative purchasing agreements—none of which match the specific drug combination named in the code. State and local procurement offices appear to be using this code inconsistently or the code itself may be misaligned with actual buying patterns in these jurisdictions.

No recent state or local government solicitations for beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide or related pharmaceutical combinations are evident in the source material. The code shows minimal actionable procurement signal. A business development professional evaluating this code should verify the UNSPSC classification with target agencies directly and consider whether the code is actively used for competitive solicitations in their target markets, or whether opportunities are being tagged under broader pharmaceutical family or class codes instead.